Integra Lifesciences Holdings (IART) Cash from Discontinued Operations (2014 - 2015)
Integra Lifesciences Holdings (IART) posted Cash from Discontinued Operations of 18937000.0 for Q2 2015, down 381.47% sequentially from 6728000.0 in Q1 2015.
Integra Lifesciences Holdings (IART) Cash from Discontinued Operations (2014 - 2015) Analysis & Trends
Integra Lifesciences Holdings has reported Cash from Discontinued Operations for 2 years, with the latest figure at 18937000.0 in Q2 2015.
- Quarterly Cash from Discontinued Operations changed N/A year-over-year to 18937000.0 in Q2 2015, while the trailing twelve-month figure through Mar 2016 was 18937000.0 (changed N/A YoY) and the FY2015 annual result came in at 12209000.0, down 159.21% from the prior year.
- Cash from Discontinued Operations declined to 18937000.0 in Q2 2015 per IART's latest filing, from 6728000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 6728000.0 in Q1 2015 and troughed at 18937000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -18.94 Mn |
| Jun 30, 2015 | -18.94 Mn |
| Mar 31, 2015 | 6.73 Mn |
| Mar 31, 2015 | 6.73 Mn |
| Dec 31, 2014 | 2.86 Mn |
| Dec 31, 2014 | 2.86 Mn |